Table 1.
Summary of homeobox gene expression and function in mammary gland development and neoplasia
Gene | Gene | Expression | Expression altered in | Mammary or in vitro | |||
family | namea | detected inb: | Methodc | neoplasias ? | Possible regulation? | phenotype? | Reference |
Hox/HOX | Hoxa-1 | MG (UD) | RT-PCR; Northern | OE (freq.) | Extracellular matrix | [31*,33*] | |
Scp2, CID-9 | components | ||||||
HOXA-1 | MCF7 | RT-PCR | Retinoic acid | [63,30] | |||
Hoxa-5 | CID-9 | RT-PCR | [33*] | ||||
Hoxa-7 | MG | RT-PCR | [31*] | ||||
HOXA-7 | MG | RT-PCR | 1 | ||||
Hoxa-9 | MG | RT-PCR | KO: lactational defects | [38*] | |||
HOXA-10 | MCF7 | RT-PCR | Vitamin D | OE in MCF7: promotes cell cycle | [30,64] | ||
arrest at G1 | |||||||
Hoxb-6 | MG | RT-PCR; Northern | Lost | [31*] | |||
HOXB-6 | MCF7 | RT-PCR | [30] | ||||
Hoxb-7 | MG (E+S) | Northern; in situ | UE | Extracellular matrix | OE in SkBr3 cells: bFGF induction; | [33*,57] | |
components; developmental | increased proliferation; decreased | ||||||
growth factor dependency | |||||||
Hoxb-8 | CID-9 | RT-PCR | [33*] | ||||
Hoxb-9 | CID-9 E12.5 | RT-PCR; in situ | KO: lactational defects | [33*,38] | |||
Embryo (MM) | |||||||
Hoxc-6 | MG | Northern | Lost | Estrogen (-); developmental | [31] | ||
HOXC-6 | MCF7; MCF7D; | cDNA screen; | Variable | [57,65] | |||
Hs578Bst; | RT-PCR | ||||||
MCF10F; T47D | |||||||
Hoxc-8 | MG | Northern | Lost | Estrogen (-); developmental | [32] | ||
HOXC-10 | MG | PCR of cDNA library | 2 | ||||
Hoxd-3 | MG (UD) | Northern | OE (rarely) | [32] | |||
Hoxd-4 | MG (E) | In situ | Lost | [32] | |||
Hoxd-8 | MG | Northern | Lost | Developmental | [32] | ||
Hoxd-9 | MG (E+S); | RT-PCR; | Lost | Developmental | KO: lactational defects | [32,38] | |
E12.5 Embryo | Northern; in situ | ||||||
(MM) | |||||||
Hoxd-10 | MG (E+S) | Northern; in situ | Lost | Developmental | KO: lactational defects | [32,39];2 | |
Hoxd-11 | MG (UD) | Northern | No | [32] | |||
Hord-12 | MG | RT-PCR; | OE (myc tumor) | [31*] | |||
Northern (UD) | |||||||
Msx | Msx-1 | E13.5 Embryo (E); | Northern; in situ | Maintained but variable | Developmental | KO: none detected in embryos | [40*,41*] |
MG (E) | |||||||
Msx-2 | E13.5 Embryo (E); | Northern; in situ | Lost | Estrogen; developmental | KO: MG fail to form | [40*];3 | |
MG (S) | |||||||
Iroquois related | IRX-1 | MG | RT-PCR | [48*] | |||
IRx-2 | MG; primary | RT-PCR; Northern; | Maintained, expression | Developmental | [48*] | ||
tumors | in situ | levels or splice form | |||||
usage may be altered | |||||||
in some tumors | |||||||
IRX-3 | MG | RT-PCR | [48*] | ||||
IRX-4 | MG | RT-PCR | [48*] | ||||
IRX-5 | MG | RT-PCR | [48*] | ||||
Paired domain | Alx-4 | MG(S) | In situ | Expression associated with | KO: none detected | [45] | |
actively condensing periductal | |||||||
stroma | |||||||
HSIX | HSIX-1 | MCF7 | OE | Expressed in S phase | OE in MCF7 abolishes X-ray induced | [58*] | |
of cell cycle | cell cycle arrest in G2 phase | ||||||
POU domain | OCT-1 | MCF7; MCF10; | RT-PCR; | [54] | |||
SkBr3;MDA- | Western EMSA | ||||||
MB453 | |||||||
Oct-1 | MG (lact.) | RT-PCR | [53] | ||||
OCT-2 | MCF7; MCF10; | ||||||
SkBr3 | RT-PCR; | [54] | |||||
Western EMSA | |||||||
OCT-3 | MG (UD); MCF7; | RT-PCR | OE (freq.) | Form with a 5 amino acid deletion | [54] | ||
MCF10; SkBr3; | detected om MCF7 cell | ||||||
primary tumors | |||||||
Oct-3 | MG (lact.) | RT-PCR | [53] | ||||
OCT-11 | MG (UD) MCF7; | RT-PCR; EMSA | OE (freq.) | [54] | |||
skBr3; MDA- | |||||||
MB453; primary | |||||||
tumors | |||||||
Pit-rs 1 | MG (lact.) | RT-PCR | [53] | ||||
Pou4f1 = Brn-3 | MG (lact.) | RT-PCR | [53] | ||||
Pou4f-rs1 = | MG (lact.) | RT-PCR | [53] | ||||
Brn-3R | |||||||
Pou3f4 = Brn-4 | MG (lact.) | RT-PCR | [53] | ||||
Pou3f-rs1 = | MG (lact.) | RT-PCR | [53] | ||||
POU-IIIA | |||||||
Engrailed related | En-1 | MG | Northern | UE (freq.) | Developmental | [32] | |
En-2 | MG (UD) | Northern | UD | KO: none detechted | [32] | ||
MOX | MOX1 | MG | [52] | ||||
MEIS | MEIS2a | MG | RT-PCR of cDNA library | 4 | |||
MEIS 2d | MG | RT-PCR of cDNA library | 4 | ||||
MRG1a | MG | RT-PCR of cDNA library | 4 | ||||
bFGF, basic fibroblast growth factor; E, epithelium; EMSA, electrophoretic mobility shift assay; freq., frequently; KO, knockout mutation; lact., lactating; M, mammary mesenchyme; MG mammary gland; Northern, Northern blot assay; OE, overexpressed; RT-PCR, reverse transcriptase polymerase chain rection; S, periductal stroma; UD, undetectable; UE, underexpressed. aHuman genes are uppercase; mouse genes are lowercase. bCalle lines are listed by their common designation. If expression was detected in the intact mammary gland, the tissue compartment is shown. cNot all detection techniques have been used on all tissue types/cell lines shown. 1Friedmann Y, Daniel CW, unpublished results; 2Lewis MT, Daniel CW, unpublished results; 3Maas R, unpublished results, cited in [41]; 4Lewis MT, unpublished results.